以妊娠部位不明为首发表现的原发性胃绒毛膜癌
37岁经产妇因阴道出血和β-hCG升高但超声未见妊娠部位而诊断为妊娠部位不明,接受甲氨蝶呤治疗。β-hCG在用药后第4至7天下降40%,一周后不适当地升至10,937毫国际单位/毫升,再次甲氨蝶呤并CT检查发现胃和肝脏病灶,胃活检病理为非妊娠性绒毛膜癌,化疗后7个月死于心脏骤停。
要点
- 妊娠部位不明患者接受甲氨蝶呤治疗后β-hCG下降不适当,需考虑恶性肿瘤异位分泌β-hCG。
- 可分泌β-hCG的恶性肿瘤包括妊娠滋养细胞疾病、性腺及性腺外生殖细胞肿瘤和伴绒毛膜癌分化的恶性肿瘤。
- 异位妊娠约占早孕期妊娠的2%,妊娠滋养细胞肿瘤和妊娠绒毛膜癌分别见于1/1,500和1/20,000妊娠。
核心结论
- 当妊娠部位不明患者接受药物管理后β-hCG水平未适当下降时,必须考虑恶性肿瘤异位分泌β-hCG。
研究设计与样本
- 病例报告:1例37岁、孕4产3013的女性,因阴道出血数天和β-hCG升高但超声未定位妊娠就诊。
主要发现
- 初始β-hCG为7,779毫国际单位/毫升时给予甲氨蝶呤,第4至7天β-hCG下降40%。
- 一周后β-hCG不适当地升至10,937毫国际单位/毫升,给予第二剂甲氨蝶呤并行计算机断层扫描,发现胃和肝脏病灶。
- 胃活检病理显示非妊娠性绒毛膜癌,患者接受化疗,诊断后7个月死于心脏骤停。
关键数值与推荐
- 异位妊娠约占早孕期妊娠的2%。
- 妊娠滋养细胞肿瘤见于1/1,500妊娠,妊娠绒毛膜癌见于1/20,000妊娠。
临床怎么用
- 妊娠部位不明患者接受药物管理后β-hCG水平未适当下降时,必须考虑恶性肿瘤异位分泌β-hCG。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnancy of unknown location presents a diagnostic challenge, in rare occasions leading to the diagnosis of malignancy. We describe a case of β-hCG-secreting nongestational primary gastric choriocarcinoma presenting as a pregnancy of unknown location. CASE: A 37-year-old woman, gravida 4 para 3013, presented with several days of vaginal bleeding and rising β-hCG level without ultrasound localization of pregnancy. The diagnosis of pregnancy of unknown location was made and methotrexate administered at a β-hCG level of 7,779 milli-international units/mL. A 40% decrease in β-hCG level was noted between days 4 and 7. One week later, an inappropriate β-hCG level rise to 10,937 milli-international units/mL was noted, prompting a second dose of methotrexate and computed tomography imaging, leading to the discovery of gastric and liver lesions. Pathology from gastric biopsies revealed nongestational choriocarcinoma. The patient was treated with chemotherapy, with death from cardiac arrest 7 months after diagnosis. CONCLUSION: Malignancies that can secrete β-hCG include gestational trophoblastic disease, gonadal and extragonadal germ cell tumors, and malignancies with choriocarcinoma differentiation. Although ectopic pregnancy compromises approximately 2% of first-trimester pregnancy, gestational trophoblastic neoplasia and gestational choriocarcinoma can be seen in 1 of 1,500 and 1 of 20,000 pregnancies, respectively. When β-hCG levels do not fall appropriately in women undergoing medical management for pregnancy of unknown location, ectopic β-hCG secretion by a malignancy must be considered.
引用
- Larish A, Kumar A, Kerr S, et al. Primary Gastric Choriocarcinoma Presenting as a Pregnancy of Unknown Location. Obstet Gynecol. 2017. PMID: 28079767. doi:10.1097/AOG.0000000000001808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。